Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam and fospropofol for painless gastrointestinal endoscopy in elderly patients
ChiCTR2600135505Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2026
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and fospropofol disodium in hypotension and anoxemia (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Time-weighted average of MAP below 65 mmHg after anesthesia. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
remimazolamfospropofol disodium
03
Conditions
hypotensionanoxemia
Beyond the preview
Go deeper on ChiCTR2600135505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135505.